Air Barrier System Device to Reduce Contamination in Posterior Spine Surgery
ABS to Reduce Contamination in Spine Surgery
1 other identifier
interventional
41
1 country
1
Brief Summary
The objective of this study is to determine whether the Air Barrier System (ABS) reduces airborne colony-forming units (e.g. bacteria) present at surgery sites during posterior spinal procedures
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable surgery
Started Nov 2011
Typical duration for not_applicable surgery
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2011
CompletedFirst Submitted
Initial submission to the registry
March 14, 2012
CompletedFirst Posted
Study publicly available on registry
March 21, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2015
CompletedResults Posted
Study results publicly available
March 17, 2015
CompletedMarch 17, 2015
March 1, 2015
3.3 years
March 14, 2012
February 25, 2015
March 16, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
CFU Density
Colony-forming unit density at incision site (CFU/m3)
Surgical case CFU density will be determined at up to 1 month from completion of surgical cases
Study Arms (2)
No device
NO INTERVENTIONSubject does not receive ABS system
Air Barrier System device
EXPERIMENTALDevice is deployed adjacent to the surgery site and activated.
Interventions
Device is deployed adjacent to the surgery site and activated.
Eligibility Criteria
You may qualify if:
- Adult patients undergoing lumbar and cervical laminectomy with instrumentation.
You may not qualify if:
- Active infection
- Prior prosthesis infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Michael E. DeBakey VA Medical Center
Houston, Texas, 77030, United States
Results Point of Contact
- Title
- Sean Self
- Organization
- Nimbic Systems
Study Officials
- PRINCIPAL INVESTIGATOR
Rabih O Darouiche, MD
Baylor College of Medicine
- PRINCIPAL INVESTIGATOR
Sean Self
Nimbic Systems
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 14, 2012
First Posted
March 21, 2012
Study Start
November 1, 2011
Primary Completion
February 1, 2015
Study Completion
February 1, 2015
Last Updated
March 17, 2015
Results First Posted
March 17, 2015
Record last verified: 2015-03